1. "Center for Molecular Imaging and Biotechnology (CMIB)"
Formats
  1. Journal Article (1668)
  2. Meeting Abstract (1151)
  3. Review (38)
  4. Editorial (35)
  5. Research Letter (28)
  6. Conference Paper (24)
  7. Book Section (10)
  8. Book Whole (3)
  9. Correspondence (3)
  10. Guidelines (3)
  11. Miscellaneous (2)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (2965)
  2. GSK Faculty (2946)
  3. Department of Medicine (1767)
  4. Human Oncology and Pathogenesis Program (1744)
  5. Department of Pathology and Laboratory Medicine (1400)
  6. Sloan Kettering Institute Postdocs (1289)

More Groups

People
  1. Michael Berger (765)
  2. David Solit (354)
  3. Nikolaus Schultz (351)
  4. Ross Levine (348)
  5. Marc Ladanyi (303)
  6. Charles Rudin (262)

More People

Years
  1. 2025 (128)
  2. 2024 (235)
  3. 2023 (219)
  4. 2022 (258)
  5. 2021 (196)
  6. 2020 (233)

More Years

Publications
  1. Journal of Clinical Oncology (306)
  2. Blood (252)
  3. Cancer Research (193)
  4. Clinical Cancer Research (119)
  5. Nature (95)
  6. Nature Communications (79)

More Publications

Publishers
  1. Nature Publishing Group (462)
  2. American Association for Cancer Research (420)
  3. American Society of Clinical Oncology (342)
  4. American Society of Hematology (272)
  5. Elsevier Inc. (196)
  6. Cell Press (183)

More Publishers

Results (2965)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic and molecular features to distinguish metastatic urothelial carcinoma in lung from primary lung squamous cell carcinoma
    Meeting Abstract

    Rammal, R.; Darmofal, M.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; Fine, S.; Tickoo, S.; Reuter, V.; Travis, W.; Berger, M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Impact of B cell immune reconstituion on non-relapse mortality in T cell depleted allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lucas, A. T.; Scordo, M.; Lakkaraja, M.; White, C.; Mauguen, A.; Shaffer, B.; Jakubowski, A.; Cho, C.; Gyurkocza, B.; Papadopoulos, E.; more...
    Cytotherapy (2025)

    Fulltext@MSK | Save
  • Safety, tolerability, and clinical assessment of bemdaneprocel for Parkinson's disease: Results through 24 months from a Phase 1 study
    Meeting Abstract

    Henchcliffe, C.; Sarva, H.; Lozano, A.; Fasano, A.; Kalia, S.; Yu, K. K. H.; Brennan, C.; Floro, N.; Stemple, W.; Abid, N.; more...
    Parkinsonism & Related Disorders (2025)

    Fulltext@MSK | Save
  • Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
    Journal Article

    Tabar, V.; Sarva, H.; Lozano, A. M.; Fasano, A.; Kalia, S. K.; Yu, K. K. H.; Brennan, C.; Ma, Y.; Peng, S.; Eidelberg, D.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with stereotactic radiosurgery
    Journal Article

    Gaeta, B.; Eichholz, J. E.; Walch, H.; Ilica, A. T.; Boe, L.; Kratochvil, L.; Yu, Y.; Gomez, D. R.; Imber, B. S.; Li, B. T.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Engineering mtDNA deletions by reconstituting end joining in human mitochondria
    Journal Article

    Fu, Y.; Land, M.; Kavlashvili, T.; Cui, R.; Kim, M.; DeBitetto, E.; Lieber, T.; Ryu, K. W.; Choi, E.; Masilionis, I.; more...
    Cell (2025)

    Fulltext@MSK | Save
  • CD8α marks a Mycobacterium tuberculosis-reactive human NK cell population with high activation potential
    Journal Article

    Mehanna, N.; Pradhan, A.; Kaur, R.; Kontopoulos, T.; Rosati, B.; Carlson, D.; Cheung, N. K. V.; Xu, H.; Bean, J.; Hsu, K. C.; more...
    Scientific Reports (2025)

    Fulltext@MSK | Save
  • Deciphering the spectra of breast cancer in multispectral optoacoustic tomography
    Conference Paper

    Bader, M.; Mc Larney, B. E.; Pinker, K.; Grimm, J.; Jüstel, D.; Ntziachristos, V.
    SPIE (2025)

    Fulltext@MSK | Save
  • Mutant IDH1 cooperates with NPM1c or FLT3(ITD) to drive distinct myeloid diseases and molecular outcomes
    Journal Article

    Sakamoto, T.; Leca, J.; Zhang, X.; Meydan, C.; Foox, J.; Ramachandran, P.; Hendrikse, L. D.; Zhou, W.; Berger, T.; Fortin, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save
  • The pentameric chloride channel BEST1 is activated by extracellular GABA
    Journal Article

    Pant, S.; Tam, S. W.; Long, S. B.
    Proceedings of the National Academy of Sciences of the United States of America (2025)

    Fulltext@MSK | Save